RxSight (RXST) Gross Profit Growth (1y) (2021 - 2026)
RxSight (RXST) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 8.95% |
| 10 | RxSight | 248.32 Mn | -155.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.05% |
| Dec 31, 2025 | -12.24% |
| Sep 30, 2025 | -3.94% |
| Jun 30, 2025 | 3.88% |
| Mar 31, 2025 | 36.95% |
| Dec 31, 2024 | 63.07% |
| Sep 30, 2024 | 83.67% |
| Jun 30, 2024 | 101.83% |
| Mar 31, 2024 | 99.55% |
| Dec 31, 2023 | 137.86% |
| Sep 30, 2023 | 156.37% |
| Jun 30, 2023 | 150.94% |
| Mar 31, 2023 | 175.62% |
| Dec 31, 2022 | 158.70% |
| Sep 30, 2022 | 299.40% |
| Jun 30, 2022 | 689.66% |
| Mar 31, 2022 | 236.10% |
| Dec 31, 2021 | 107.90% |
| Sep 30, 2021 | 86.25% |
| Jun 30, 2021 | -71.31% |